Pharmacological options for diabetes treatment include sulfonylureas, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptide-4 (DPP-4) inhibitors (38); while non-pharmacological strategies involve regulating dietary energy intake, increasing physical activity, and enhancing energy expenditure (39). The gene discussed is DPP4; the disease is diabetes mellitus.